|
Volumn 10, Issue 9, 2002, Pages 692-706
|
A slow release formulation of insulin as a treatment for osteoarthritis
a a a a a a a |
Author keywords
Cartilage; Growth factors; Insulin; Matrix breakdown; Osteoarthritis
|
Indexed keywords
AGGRECANASE;
INTERLEUKIN 1;
NITRIC OXIDE;
POLYGLACTIN;
PROTEOGLYCAN;
RECOMBINANT HUMAN INSULIN;
RECOMBINANT SOMATOMEDIN C;
SOMATOMEDIN C RECEPTOR;
AGE;
AGING;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ARTICULAR CARTILAGE;
CARTILAGE DEGENERATION;
CARTILAGE MATRIX;
CELL PROLIFERATION;
CELL TYPE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG ACTIVITY;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SPECIFICITY;
DRUG STABILITY;
ENZYME INHIBITION;
EXPLANT;
FEMALE;
FIBROBLAST;
GUINEA PIG;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VITRO STUDY;
IN VIVO STUDY;
INCIDENCE;
KNEE OSTEOARTHRITIS;
MALE;
NONHUMAN;
OSTEOBLAST;
PRIORITY JOURNAL;
PROTEIN SECRETION;
PROTEIN SYNTHESIS;
SLOW RELEASE FORMULATION;
|
EID: 0036714542
PISSN: 10634584
EISSN: None
Source Type: Journal
DOI: 10.1053/joca.2002.0813 Document Type: Article |
Times cited : (40)
|
References (49)
|